[VRDN] QoQ Quarter Result on 31-Dec-2019 [#Q4]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
12-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- 9.90%
YoY- 1.93%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 0 168 828 880 695 2,514 372 -
PBT -5,494 -6,435 -8,044 -10,118 -11,230 -8,896 -11,629 -39.25%
Tax -48 33 27 50 133 204 339 -
NP -5,494 -6,435 -8,044 -10,118 -11,230 -8,896 -11,629 -39.25%
Tax Rate - - - - - - - -
Total Cost 5,494 6,603 8,872 10,998 11,925 11,410 12,001 -40.51%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin 0.00 -3,830.36 -971.50 -1,149.77 -1,615.83 -353.86 -3,126.08 -
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS -1.48 -1.82 -2.65 -4.69 -5.42 -4.31 -5.65 -58.96%
EPS Diluted -1.48 -1.82 -2.65 -4.69 -5.42 -4.31 -5.65 -58.96%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.